Management of Persistent Nocturnal Enuresis in an 11-Year-Old Girl
Start with an enuresis alarm as first-line therapy, as it has the highest long-term cure rate (66% initial success with over half maintaining dryness) and is the most benign treatment option. 1, 2
Initial Assessment and Baseline Interventions
Before initiating specific therapy, address these foundational elements:
Essential History Points
- Voiding pattern: Ask specifically about urgency, holding maneuvers (standing on tiptoe, heel pressing into perineum), interrupted stream, weak flow, or need for abdominal straining 1
- Frequency: Document if wetting occurs nightly or sporadically (frequent wetting = poorer prognosis) 1
- Bowel habits: Constipation must be identified and treated first—if movements occur every 2+ days or stool is hard, this blocks enuresis treatment success 1
- Daytime symptoms: Any daytime incontinence, urgency, or frequency changes this to non-monosymptomatic enuresis requiring different management 1
Required Documentation
Have the family complete a frequency-volume chart for 2-3 days documenting:
- All fluid intake volumes and timing
- All void times and volumes
- Wet/dry nights on a calendar 1
This provides objective data on bladder capacity and nocturnal urine production patterns.
Immediate Behavioral Modifications
- Treat constipation aggressively: Daily soft stool is mandatory. Use polyethylene glycol if needed 1
- Structured voiding schedule: 7 voids daily—morning, twice at school, after school, dinner time, bedtime, and upon waking 1
- Fluid redistribution: Liberal intake during morning/early afternoon, then limit evening to ≤200 ml (6 oz) after dinner with nothing after that 1
- Eliminate caffeine completely 2
- Keep a dry/wet night calendar: This alone has independent therapeutic benefit 1
First-Line Treatment Algorithm
Option 1: Enuresis Alarm (Preferred for Long-Term Cure)
This is the gold standard for sustained dryness with 66% achieving <1 wet night/month and >50% maintaining long-term success 2. Meta-analyses show it outperforms both imipramine and desmopressin for durability 2.
Implementation details:
- Requires motivated child and family commitment
- Expect 8-16 weeks for full effect
- Child must be involved in changing sheets (consciousness-raising)
- Monthly follow-up to maintain motivation improves outcomes 1
When alarm is NOT appropriate:
- Family cannot commit to nightly monitoring
- Child has severe sleep issues
- Immediate dryness needed for specific events (camps, sleepovers)
Option 2: Desmopressin (For Rapid Effect or Alarm Failure)
Use when alarm therapy failed, family unlikely to comply with alarm, or child has documented nocturnal polyuria (nighttime urine production >130% of expected bladder capacity) 1.
Dosing specifics:
- Tablets: 0.2-0.4 mg taken 1 hour before sleep 1
- Oral melt: 120-240 mcg taken 30-60 minutes before bed 1
- Dose is NOT weight-based—same for all ages 1
- Effect is immediate if it works 1
- 30% achieve complete dryness, 40% partial response 1
Critical safety warning:
- Restrict evening fluids to ≤200 ml (6 oz) maximum to prevent water intoxication with hyponatremia and seizures 1
- Use oral formulations only—nasal spray has higher complication risk and is contraindicated 1
- Polydipsia is an absolute contraindication 1
Management strategy:
- If effective, family can choose daily use or only for important nights 1
- Schedule regular 1-2 week drug holidays every 3 months to assess ongoing need 1
- Low curative potential—primarily suppressive 1
Second-Line Treatment (Therapy-Resistant Cases)
If alarm and desmopressin both fail individually:
Combination Therapy
Desmopressin at standard dose PLUS anticholinergic works in ~40% of treatment-resistant cases 1
Before adding anticholinergics, you MUST:
- Complete frequency-volume chart
- Perform uroflowmetry with post-void residual ultrasound
- Confirm constipation is treated
- Establish regular voiding habits 1
Anticholinergic options:
- Tolterodine 2 mg at bedtime (may double if needed) 1
- Oxybutynin 5 mg at bedtime (may double) 1
- Propiverine 0.4 mg/kg at bedtime (may double) 1
Expect response within 2 months maximum 1
Critical monitoring:
- Watch for constipation (most common side effect—may herald treatment failure) 1
- Monitor for post-void residual causing UTIs—family must report dysuria or fever immediately 1
- Mood changes possible but uncommon with tolterodine/propiverine 1
Third-Line Treatment (Tertiary Care Only)
Imipramine 25-50 mg at bedtime (50 mg for children >9 years) is reserved for:
- Failure of alarm AND family cannot afford desmopressin 1
- Tertiary care facilities only due to safety concerns 1
Major safety concerns:
- Potentially fatal cardiotoxicity with overdose 1
- Must be locked away from siblings 1
- Screen for palpitations, syncope, family history of sudden cardiac death or arrhythmia—if present, obtain prolonged ECG to exclude long QT before prescribing 1
- 50% response rate but high tolerance risk 1
- Requires drug holidays of 2+ weeks every 3 months 1
Common Pitfalls to Avoid
- Not treating constipation first—this alone can block all other therapies from working 1
- Inadequate fluid restriction with desmopressin—serious hyponatremia risk 1
- Using nasal desmopressin—higher complication rates, use oral only 1
- Starting anticholinergics without proper evaluation—risk of urinary retention and UTIs 1
- Lifting child at night without their awareness—one study showed this was less successful than no treatment 2
- Not involving the child—motivation and participation are critical for success 1